Skip to main content
Drug Metabolism and Disposition logoLink to Drug Metabolism and Disposition
. 2025 Sep 25;54(2):100174. doi: 10.1016/j.dmd.2025.100174

Single-cell transcriptomics showed that maternal polychlorinated biphenyl exposure dysregulated cell type-specific metabolic responses in the livers of female mouse offsprings

Joe Jongpyo Lim 1,2,3, Youjun Suh 1,2,4, Xueshu Li 5, Rebecca J Wilson 6, Hans-Joachim Lehmler 5, Pamela J Lein 6, Julia Yue Cui 1,2,4,∗
PMCID: PMC13632513  PMID: 41520576

Abstract

Polychlorinated biphenyls (PCBs) are persistent environmental toxicants that bioaccumulate in the food chain and readily cross the placenta, raising concerns for developmental toxicity. Although PCB exposure has been associated with metabolic and neurodevelopmental disorders, its cell type-specific effects on liver development remain poorly understood. This study aimed to investigate how maternal exposure to an environmentally relevant Fox River PCB mixture affects liver development in female offspring at single-cell resolution. We hypothesized that developmental PCB exposure disrupts hepatic metabolic and immune function in a cell-type-specific manner. Using single-cell RNA sequencing on liver tissue from postnatal day 28 female mice exposed to PCBs throughout gestation and lactation, we identified major hepatic and immune cell populations and assessed cell-specific transcriptional responses. PCB exposure significantly altered the proportions of endothelial cells and Kupffer cells and reduced neutrophil abundance in the liver. Transcriptomic analysis revealed that PCBs dysregulated key functional pathways in hepatocytes and nonparenchymal cells, including endoplasmic reticulum stress responses, drug metabolism, and glucose/insulin signaling. Notably, hepatocytes exhibited upregulation of phase I drug-metabolizing enzymes and uptake transporters, but downregulation of phase II enzymes and efflux transporters. Kupffer cells and endothelial cells exhibited altered immune and metabolic gene expression, and intercellular communication analysis predicted that PCB exposure disrupted fibronectin, collagen, and chemokine signaling. Reverse transcription-quantitative polymerase chain reaction validation confirmed increased expression of hepatic endoplasmic reticulum stress markers. Together, these findings demonstrate that developmental PCB exposure induces persistent, cell-type-specific transcriptomic reprogramming in the liver, impairing metabolic and immune functions. This study highlights the utility of single-cell transcriptomics for revealing toxicant effects with cellular precision during critical windows of development.

Significance Statement

Our findings showed that developmental exposure to a persistent organic pollutant led to transcriptomic changes that differed across cell types that form the liver. Our study highlights the use of single cell technology to investigate toxic effects for mechanistic insights with greater precision.

Key words: Polychlorinated biphenyls, Liver, Single-cell RNA-seq, Developmental exposure, Persistent organic pollutants, Liver physiology

1. Introduction

Polychlorinated biphenyls (PCBs) are persistent organic compounds that were widely used as electrical coolants and insulators, hydraulic fluids, and plasticizers.1 Although PCBs have been banned from commercial production in the United States since the 1970s2 and global production in the 2000s,3 they persist in the environment and bioaccumulate in food chains4 and humans,5 which raises human health concerns. PCBs have been detected in various food items, including meat, milk, fish, and eggs and can cross the placental barrier and are excreted through breast milk,6, 7, 8 suggesting that early life may be a critical window of vulnerability to PCB exposure.

Exposure to PCBs is linked to immune system dysfunction,9 reproductive toxicity,9,10 cardiovascular diseases,11 and neurodevelopmental toxicity.3,12,13 Epidemiology studies showed that developmental exposure to PCBs is linked to cognitive development and attention issues.3,14 In rodent models, perinatal exposure to PCBs resulted in reduced vocalizations, increased repetitive behavior, and social deficits,15 gut barrier defects and increased inflammation,16 as well as endocrine disruption including dysregulation of estrogen receptor alpha signaling.17 Developmental exposure during pregnancy and lactation to the Fox River PCB mixture, an environmentally relevant PCB mixture,18 impairs social communication related to neurodevelopmental disruption in mice.19 Exposure to the Fox River PCB mixture during pregnancy altered metabolites involved in glucuronidation and heme and amino acid metabolism in serum, suggesting potential contribution to developmental neurotoxic effects of the pups.20

The liver is a major organ for xenobiotic biotransformation and nutrient homeostasis21 and is a target organ for PCB exposure. Previous work showed that PCB exposure is positively associated with prevalence of metabolic disorders and liver diseases in human populations.22,23 In laboratory studies, subchronic PCB exposure resulted in lipid accumulation and steatohepatitis signatures in rats.24 PCB exposure led to hepatic fibrosis, inflammation, and metabolic dysfunction, which were exacerbated from diet-induced liver injury in mice.25, 26, 27 We previously showed that acute exposure to the Fox River PCB mixture altered bile acid homeostasis within the gut-liver axis,28 and that the gut microbiome is necessary for PCB-induced changes in the hepatic transcriptome including dysregulation of xenobiotic and steroid metabolism in adult mice.29 However, the effects of PCB exposure on liver development during early life—particularly its impact on metabolic and immune regulatory pathways—remain poorly understood. In particular, how PCBs influence liver maturation at single-cell resolution and with cell-type-specific precision during critical windows of development has yet to be fully elucidated.

The liver is composed of multiple cell types, each with specialized roles in metabolism, immunity, and tissue maintenance. Hepatocytes are the main functional cells important for xenobiotic biotransformation.30,31 Cholangiocytes are important for bile acid modification and transport.32 Endothelial cells mediate exchange between blood and liver cell types.33 Stellate cells store vitamin A, regulate extracellular matrix production, and transform into hepatic myofibroblasts upon activation and in response to inflammatory signals.31,33,34 Kupffer cells are liver-resident macrophages involved in hepatic immune surveillance. Other immune cell populations that reside in and circulate around the liver are also present at steady state, including B cells, T cells, natural killer (NK) cells, conventional and plasmacytoid dendritic cells (cDC and pDC, respectively), monocytes, and monocyte-derived macrophages (MDM), neutrophils, and mast cells.31,34,35 Understanding the changes caused by PCB exposure during critical developmental time windows at the single-cell level is crucial for elucidating cell-type-specific responses and interactions that can provide mechanistic insights. Therefore, in the present study, we performed single-cell RNA sequencing (scRNA-seq) in the offspring that were developmentally exposed to PCBs. We hypothesized that maternal PCB exposure during gestation and lactation leads to cell-type-specific responses involved in metabolic dysregulation in the livers of the offspring.

2. Materials and methods

2.1. Chemicals

The Fox River PCB mixture was prepared from technical PCB mixtures, ie, Aroclors 1242 (lot#:0114-A), 1248 (lot#:1063-248), 1254 (lot#:124-191-B), and 1260 (lot#:021-020-1A), purchased from AccuStandard Inc. Each Aroclor was prepared in pesticide-grade acetone (50 mg/mL) acetone (Fisher Scientific) and mixed at a ratio of 35:35:15:15, respectively, by weight. The acetone was then evaporated under a gentle nitrogen flow, and the resulting PCB mixture was characterized by gas chromatography tandem mass spectrometry.36 The PCB mixture was dissolved in organic peanut oil (Spectrum Organic Products, LLC) at a stock concentration of 20 mg/mL and stored in amber glass vials at −20 °C. The full details of the PCB composition and mixture generation methods are described in the study by Li et al37 and are provided in Supplemental Table 1.

2.2. Animals and chemical exposure

All mice were housed according to the Association for Assessment and Accreditation of Laboratory Animal Care International guidelines (https://aaalac.org/resources/theguide.cfm). All experiments were approved by the Institutional Animal Care and Use Committee at the University of Washington. Three-month-old specific pathogen free-free female C57BL/6J mice were purchased from the Jackson Laboratory and were acclimated to the animal facility at the University of Washington at 74 °F, 26% humidity, and 12-hour light and dark cycle for 1 week before the experiment. All mice had ad libitum access to standard laboratory autoclaved rodent diet (LabDiet No. 5010 after weaning and LabDiet No. 5021 for breeding; LabDiet) and water (nonacidified autoclaved water). Animals were housed with autoclaved bedding (autoclaved Enrich-N’Pure; Andersons). From 2 weeks before mating, female dams were exposed to organic peanut oil mixed with organic peanut butter (vehicle, Trader Joe’s) or the Fox River PCB mixture in vehicle (6 mg/kg body weight) once daily until pups were weaned at postnatal day 21. Female mouse livers of the pups at postnatal day 28 were collected. Female mice were used in this study to compare results with previous publications on PCB-mediated developmental neurotoxicity and as a follow-up to our previous work.19,28,29,38 The experimental design is summarized in Supplemental Fig. 1.

2.3. Liver dissociation

Fresh whole livers were rinsed with Dulbecco’s phosphate-buffered saline (DPBS) (Cat No. 14190136, Thermo Fisher Scientific) and were minced into 1–3 mm pieces using surgical scissors. The minced livers were then placed in 15 mL conical tubes containing 10 mL of DPBS. Using serological pipettes, the DPBS was replaced by 10 mL of dissociation enzyme mixtures containing Liberase (Cat No. 540115001, Sigma Aldrich) and Dispase II (Cat No. D4693-1G, Sigma Aldrich) dissolved in Hanks’ balanced salt solution (Cat No. 14025-092, Thermo Fisher Scientific). The tubes containing the liver and enzyme mix were incubated at 37 °C for 40 minutes using a Roto-Therm H2020 incubator (Benchmark Scientific Inc). After the incubation, the cells and undissociated fragments were strained using a 40-micron cell strainer. Strained cells were centrifuged at 300 g for 5 minutes at 4 °C and resuspended in a 5-mL red blood cell lysis buffer on ice for 8 minutes. Cells were centrifuged again at 300 g for 5 minutes at 4 °C. Dead and dying cells were filtered using the Dead Cell Removal Kit (Miltenyi Biotec) following the manufacturer’s instructions. The viability was checked using a hemocytometer under a light microscope (Labophot-2, Nikon). Samples with >85% viability were then cryopreserved using 10% DMSO (Cat No. BP231-100, Thermo Fisher Scientific) and 90% FBS (Cat No. F2442-50ML, Sigma Aldrich) until further analysis.

2.4. Single-cell RNA sequencing

Cryopreserved cells were thawed using a water bath at 37 °C for 2 minutes, followed by serial dilution in DPBS until 32 mL was reached. Cells were centrifuged and resuspended in DPBS until a concentration of approximately 100 cells/μL was reached. The resuspended cells in biological triplicates (n = 3), targeting 10,000 cells per sample, were then subject to scRNA-seq using a Chromium Next GEM single cell 3′ v3.1 kit and a Chromium X controller (10X Genomics) following the manufacturer’s instructions. The created libraries were then sequenced using the NovaSeq platform.

2.5. Total RNA extraction and reverse transcription-quantitative polymerase chain reaction

Total RNA was isolated from the large intestine using RNA-Bee (Tel-Test Inc). RNA concentrations were quantified using a NanoDrop 1000 Spectrophotometer (Thermo Scientific) at 260 nm. The integrity of the total RNA samples was evaluated by formaldehyde-agarose gel electrophoresis, with visualization of the 18S and 28S rRNA bands under UV light. Extracted RNA samples were then reverse transcribed to cDNA using a High-Capacity cDNA Reverse Transcription Kit (Thermo Scientific). The resulting cDNA products were amplified by quantitative polymerase chain reaction (qPCR), using a Sso Advanced Universal SYBR Green Supermix in a Bio-Rad CFX384 Real-Time PCR Detection System (Bio-Rad).

2.6. Data processing and statistical analysis

Raw scRNA-seq data were processed using the Cell Ranger v7.0 (10X Genomics). Processed data were read into R version 4.2.2 (R Core Team, 2023) for further analyses. Filtering and normalization were performed using the default parameters using Seurat v5. All cells with numbers of genes <200, total reads >20,000, and mitochondrial RNA percent <40 were filtered out to account for low-quality cells, doublets, and dying cells, respectively. Clustering was performed using the first 50 principal components. Cell clusters between the vehicle and PCB-exposed groups were integrated before cell type labeling using Harmony.39 The proportion of cell types in vehicle or PCB-exposed livers were compared using a 2-tailed t test with unequal variance (P < .05). Cell type labeling was performed using differentially expressed genes with the FindAllMarkers function in Seurat, using the default parameters (Bonferroni-adjusted P value < .05). Cell-cell communication analysis was done using the CellChat (v. 1.5) package.40 The intercellular communication results were selected based on significantly enriched predicted signaling with an information flow (sum of log probability) cutoff of 10. Gene ontology enrichment was done using the topGO (v.2.48.0) package41 using all detected genes as the background. Heatmaps were created using the ComplexHeatmaps (v. 2.13.1) package.42,43 All other plots were created using ggplot2 (v. 3.3.6).

Reverse transcription-qPCR (RT-qPCR) data were normalized to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (Gapdh) using the ΔΔCq method and expressed as % of Gapdh. Primer sequences are shown in Supplemental Table 2. Statistical significance was determined using a 2-tailed t test with assumption of unequal variance (P < .05).

3. Results

3.1. Cell-type-specific responses following developmental exposure to PCBs

We used scRNA-seq to profile changes in cell type-specific signatures following perinatal exposure to PCBs. The clusters of liver cells representing the major cell types are shown in Fig. 1A and Supplemental Fig. 2. The cell types identified through scRNA-seq include (1) resident liver cell types (hepatocytes, cholangiocytes, endothelial cells, stellate cells, myofibroblasts, and Kupffer cells), and (2) circulating immune cell types that reach the liver (B cells, T cells, NK cells, monocyte and MDM, cDC and pDC, respectively, and mast cells). Cell types were labeled using established marker genes that are uniquely expressed in each cell type and are widely used in other scRNA-seq analysis pipelines.44, 45, 46 Each marker gene was highly expressed in the corresponding liver cell type with a high proportion of expression (Fig. 1B).

Fig. 1.

Fig. 1

Clustering and visualization of marker genes in each cell type of the liver. (A) Visualization of cell clusters with cell types identified using marker gene expression. (B) Representation of key marker genes for cell type labeling. (C) Changes in proportions of liver cell types following developmental exposure to PCBs. The Y-axis shows the fold change in each cell type of the PCB-exposed group over that of the vehicle-exposed group. Asterisks represent P value (2-tailed t test with unequal variance assumption). (D) Total number of differentially expressed genes (Bonferroni-adjusted P value < .05) for each liver cell type from perinatal exposure to PCBs.

Each hepatic cell type performs specialized functions, and certain chemicals may preferentially impact specific cell populations.45,47,48 To determine whether early PCB exposure alters liver cellular composition, we analyzed cell-type proportions using scRNA-seq. We observed an increase in endothelial cell and Kupffer cell populations alongside a decrease in neutrophil populations in PCB-exposed offspring compared with vehicle controls (Fig. 1C).

To characterize cell-type-specific transcriptomic alterations resulting from developmental PCB exposure via the maternal diet, we performed differential expression analysis for each liver cell type (Fig. 1D; Supplemental Table 3). Overall, PCBs mostly impacted the transcriptomic signatures in resident liver cell types compared with circulating immune cell types. Among resident cells, Kupffer cells exhibited the highest number of differentially expressed genes (DEGs), followed by hepatocytes, endothelial cells, and myofibroblasts.

To gain further insights into cell-type-specific transcriptomic alterations by developmental PCB exposure, we performed gene ontology enrichment analysis on the DEGs identified in each cell (Fig. 2). The 4 cell types with the highest number of DEGs exhibited distinct response patterns following developmental PCB exposure. In Kupffer cells, from developmental PCB exposure, genes associated with cell migration, cytoskeleton organization, and signal transduction were upregulated, whereas genes related to endocrine protein response and immune response were downregulated (Fig. 2A). In hepatocytes, genes involved in aerobic energy were upregulated, whereas genes related to xenobiotic biotransformation and peptide hormone response were downregulated from developmental exposure to PCBs (Fig. 2B). Endothelial cells displayed upregulation of genes involved in cell migration and vascular endothelial growth factor signaling, alongside downregulation of interferon signaling and innate immune response-related genes from developmental exposure to PCBs (Fig. 2C). In myofibroblasts, genes linked to cellular lipid efflux were upregulated; in contrast, those associated with endoplasmic reticulum (ER) stress were downregulated from developmental exposure to PCBs (Fig. 2D).

Fig. 2.

Fig. 2

Top 5 up- and downregulated gene ontology enrichment results in Kupffer cells (A), hepatocytes (B), endothelial cells (C), and myofibroblasts (D) following perinatal exposure to PCBs. Dotted lines represent -log10 false discovery rate (FDR)-adjusted P value at .05.

In other liver cell types, developmental exposure to PCBs produced distinct transcriptomic changes across various biological functions. In stellate cells, genes involved in growth factor response and angiogenesis were upregulated, whereas those related to xenobiotic and sterol metabolism were downregulated from developmental PCB exposure (Supplemental Fig. 3A). In cholangiocytes, genes associated with cellular lipid transport and clearance were upregulated from developmental PCB exposure (Supplemental Fig. 3B). In MDMs, genes involved in the regulation of hematopoiesis and cell adhesion, and metal ion response were upregulated, whereas chemotaxis-related genes were downregulated from developmental PCB exposure (Supplemental Fig. 3C). In B cells, T cells, and NK cells, genes involved in fatty acid and xenobiotic metabolism were upregulated from developmental PCB exposure (Supplemental Fig. 4, A–C). In both cDCs and pDCs, genes related to sterol and lipid transport and metabolism were upregulated from developmental PCB exposure (Supplemental Fig. 4, D and E). Collectively, these findings demonstrate that the hepatic transcriptomic response to developmental PCB exposure is highly cell-type specific.

3.2. Upregulation of major drug-processing genes following perinatal exposure to PCBs

One major function of the liver is xenobiotic biotransformation through drug-processing genes that encode for enzymes in phase I and phase II metabolism, as well as transporters.49 We and others have previously shown that both acute and early-life exposure to environmental toxicants, including PCBs, bisphenol A, and polybrominated diphenyl ethers, dysregulate the hepatic transcriptome and functions. Furthermore, we recently demonstrated that in addition to hepatocytes, the gene expression landscape varies within hepatic cell types, with nonparenchymal cells expressing unique portfolios of drug-processing genes.44,45 Therefore, we further investigated the cell-type-specific changes in drug-processing gene expression following developmental PCB exposure.

Dioxin-like PCBs are known to activate the aryl hydrocarbon receptor (AHR) with cytochrome P450 (Cyp) 1a2 as the prototypical target.50 In contrast, non-dioxin-like PCB congeners activate constitutive androstane receptor (CAR) and pregnane X receptor (PXR), with Cyp2b10 and Cyp3a11 as their prototypical targets, respectively.51 The Fox River PCB mixture contains both dioxin-like and non-dioxin-like PCB congeners.18 In addition, some PCB congeners have been shown to activate the lipid-sensing nuclear receptor peroxisome proliferator-activated receptor alpha (PPARα),52,53 with Cyp4a10 being a prototypical target gene.54 Consistent with this, developmental exposure to the Fox River PCB mixture upregulated the prototypical target genes of AHR, PXR, CAR, and PPARα in hepatocytes (Fig. 3A). RT-qPCR using liver homogenates showed that the expression of AHR, PXR, and CAR were not altered, and the expression of PPARα was downregulated from developmental PCB exposure (Supplemental Fig. 5). These results suggest that developmental PCB exposure may activate AHR, PXR, and CAR via ligand binding and not mRNA induction, or the increase in transcription of the receptors may be delayed and are regulated via secondary or compensatory mechanisms.

Fig. 3.

Fig. 3

Dysregulated expression signatures of drug-processing genes in resident hepatic cell populations following perinatal exposure to PCBs. (A) Violin plots that describe the distribution of expression of prototypical target genes of AHR), PXR, CAR, and PPARα from perinatal exposure to PCBs. Asterisks represent Bonferroni-adjusted P value < .05. (B) Phase I drug-processing enzymes that were differentially expressed (rows) in at least one of the major hepatic resident cell types (columns) with xenobiotic biotransformation capabilities are shown in a heatmap (left side). The colors in the heatmap represent the log2 fold change of liver genes in PCB-exposed pups compared to the vehicle control. “Direction” indicates whether a gene is up- (orange) or down- (green) regulated from perinatal exposure to PCBs (Bonferroni-adjusted P value < .05). (C) Phase II enzymes and transporters involved in xenobiotic metabolism processes that were differentially expressed (rows) in at least one of the major hepatic resident cell types (columns) with xenobiotic biotransformation capabilities are shown in a heatmap (left side). The colors of the heatmap represent the log2 fold change of liver genes of the PCB-exposed pups as compared to the vehicle control. “Direction” indicates whether a gene is up- (orange) or down- (green) regulated from perinatal exposure to PCBs (Bonferroni-adjusted P value < .05).

Developmental PCB exposure broadly dysregulated drug-processing genes across multiple liver cell types. In hepatocytes, most differentially expressed phase I enzymes were upregulated by developmental PCB exposure (Fig. 3B), including those in the Cyp2, aldo-keto reductases (Akr), aldehyde dehydrogenases (Aldh), and carboxylesterases (Ces) families. Conversely, many phase II enzymes were downregulated in hepatocytes (Fig. 3C), despite some upregulation in glutathione-S transferase (Gst), sulfotransferase (Sult), and UDP glucuronosyltransferase (Ugt) families. Notably, key synthetases for phase II enzyme cofactors, including UDP-glucose pyrophosphorylase 2 (Ugp2, for synthesizing UDP-glucuronic acid), glutamate-cysteine ligase catalytic subunit (Gclc, for synthesizing glutathione), and 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (Papss2, for synthesizing PAPS) were downregulated, potentially limiting conjugation capacity.

Transporter expression was also dysregulated by developmental PCB exposure in hepatocytes (Fig. 3C). Most upregulated transporters were basolateral uptake transporters, including solute carrier family (Slc) 10a1 (sodium-taurocholate cotransporting polypeptide, Ntcp), Slc22a1 (organic cation transporter 1, Oct1), and solute carrier organic anion transporter (Slco) 1b2 (organic anion transporting polypeptide 1b2, Oatp1b2). In contrast, except for ATP-binding cassette (Abc) c4 (multidrug resistance protein 4, Mrp4), which was upregulated by PCBs, most downregulated transporters were efflux transporters, including Abcc2 (Mrp2), Abcc6 (Mrp6), Abcb11 (Bsep), Abcb4 (Mdr2), and Slc47a1 (multidrug and toxin extrusion protein 1 [Mate1]). The bidirectional equilibrative nucleoside transporter 1 (Ent1/Slc29a1), as well as the uptake transporters of Slc22a5 (novel organic cation transporter, Octn2) and Slco1a4 (Oatp1a4), were downregulated by PCBs.

Developmental exposure to PCBs also led to sparse but notable dysregulation of drug-processing genes in multiple resident liver cell types, including endothelial cells, cholangiocytes, stellate cells, and myofibroblasts. Most phase I metabolism genes were upregulated in hepatocytes but downregulated in nonparenchymal cells (Fig. 3B). Notably, some genes that were upregulated in hepatocytes, such as members of the Ces and Cyp families, Gpx1, and Adh1, were concurrently downregulated in nonparenchymal cells. Similarly, Gsta3 and Mat1a were upregulated in hepatocytes but downregulated in stellate cells. These opposing patterns suggest distinct cell-type-specific transcriptional regulation by PCBs.

A subset of drug-processing genes, including Cyp4b1, Cyp26b1, Akr1a1, Ugdh, Papss2, Slco3a1, and Slc29a1, exhibited higher expression in nonparenchymal cells compared with hepatocytes under basal conditions (Supplemental Fig. 6), consistent with our previous characterization on basal expression patterns in liver cell types.44 However, the majority of dysregulated drug-processing genes, in both control and PCB-exposed groups, were most highly expressed in hepatocytes (Supplemental Fig. 6), suggesting that nonparenchymal cells are unlikely to fully compensate for hepatocyte-specific dysregulation.

3.3. Downregulation of insulin signaling and glucose metabolism-related genes from developmental exposure to PCBs

Interestingly, of all liver cell types detected, most resident liver cell types, except cholangiocytes, exhibited downregulated responses related to insulin signaling and glucose metabolism. Notably, a subset of genes involved in glucose response was upregulated in hepatocytes (Fig. 4A; Supplemental Table 4). Genes involved in insulin stimulus response were downregulated in both hepatocytes and Kupffer cells, whereas genes involved in insulin receptor signaling were downregulated in hepatocytes and myofibroblasts. In endothelial cells, genes involved in glucose storage and transport were downregulated, along with both hepatocytes and endothelial cells exhibiting decreased expression of genes involved in glucose homeostasis. Additionally, genes related to glucose metabolism were downregulated in both hepatocytes and stellate cells. Other downregulated gene ontology terms in hepatocytes include insulin receptor signaling and intracellular glucose homeostasis.

Fig. 4.

Fig. 4

(A) Representation of upregulated cell-type-specific gene ontology terms related to insulin signaling and glucose homeostasis from perinatal PCB exposure. Red and blue show up- and downregulated gene ontology terms, respectively. Color gradient indicates –log10 transformed false discovery rate (FDR)-adjusted P value. (B) Number of up- and downregulated genes related to glucose and insulin signaling in hepatocytes. (C) mRNA expression of genes involved in insulin signaling and energy metabolism by RT-qPCR in livers perinatally exposed to PCBs. Asterisks show P value < .05 (2-tailed t test with assumption of unequal variance). (D) Downregulated expression of glucose and insulin signaling markers in hepatocytes. Gray and red indicate low and high expression, respectively.

Overall, the majority of downregulated genes related to insulin signaling and glucose metabolism were identified in hepatocytes (Fig. 4A), suggesting that hepatocytes are the primary targets of metabolic disruption in the liver following developmental PCB exposure. To determine the overall directionality of these pathway signatures, we compared the number of upregulated and downregulated genes involved in insulin and glucose metabolism in hepatocytes. Our findings showed a greater number of downregulated genes than upregulated genes (Fig. 4B). We performed RT-qPCR using mouse liver homogenates to gain additional biological insights regarding insulin signaling and energy metabolism. Insulin-induced gene 1 (Insig1) and ATP citrate lyase (Acly) are involved in energy metabolism downstream of insulin signaling.55, 56, 57 Insig1 inhibits lipogenesis by retaining sterol regulatory element binding protein (SREBP) in the ER,58 and Acly promotes acetyl CoA production for lipid synthesis.59 Developmental PCB exposure downregulated the expression of Insig1 and Acly in the liver (Fig. 4C). Additional representative examples of key downregulated genes are shown in Fig. 4D. These include glucose 6-phosphatase (G6pc), a key enzyme in glucose metabolism during gluconeogenesis and glycogenolysis,60 insulin receptor substrate 2 (Irs2), which mediates hepatic insulin signaling and regulates glucose and lipid metabolism,61 and insulin receptor (Insr).62 Other notable genes include carnitine palmitoyltransferase 1A (Cpt1a), a key regulator of fatty acid import for hepatic β-oxidation,63 insulin-induced gene 2 (Insig2), which inhibits SREBP activation, thereby suppressing lipid biosynthesis,64 and leptin receptor (Lepr), which mediates leptin signaling and influences insulin sensitivity.65 In summary, these findings suggest that developmental PCB exposure leads to metabolic dysfunction in hepatocytes, as indicated by the predominant downregulation of key genes involved in insulin signaling and glucose homeostasis.

3.4. Upregulation of ER stress-related responses from developmental exposure to PCBs

In hepatocytes, developmental exposure to PCBs upregulated genes involved in ER stress. Specifically, genes related to both the positive and negative regulation of ER stress, as well as ER stress-induced apoptosis were upregulated (Fig. 5A). In contrast, genes related to ER stress, unfolded protein response (UPR), topologically incorrect protein response, inositol-requiring transmembrane kinase/endonuclease (Ire1)-mediated UPR were downregulated in endothelial cells and myofibroblasts. Meanwhile, in pDCs and T cells, genes involved in protein folding and protein refolding were upregulated following developmental exposure to PCBs (Fig. 5A).

Fig. 5.

Fig. 5

(A) Representation of upregulated cell type-specific gene ontology terms related to insulin signaling and glucose homeostasis from perinatal PCB exposure. Red and blue show up- and downregulated gene ontology terms, respectively. Color gradient indicates –log10 transformed FDR-adjusted P value. (B) Average expression of ER stress markers in hepatic cell types following perinatal PCB exposure. Red and blue colors represent up- and downregulation, respectively. Vehicle-exposed and PCB-exposed groups are represented by circles and triangles, respectively. Asterisks indicate differential expression (Bonferroni-adjusted P value < .05). (C) Upregulated mRNA expression of ER stress markers by RT-qPCR in livers perinatally exposed to PCBs. Asterisks show P value < .05 (2-tailed t test with assumption of unequal variance).

Overall, developmental PCB exposure upregulated ER stress markers in multiple cell types, except for myofibroblasts (Fig. 5B). Specifically, X-box binding protein 1 (Xbp1) was upregulated in hepatocytes, whereas stress-associated endoplasmic reticulum protein 1 (Serp1) was upregulated in Kupffer cells. Regarding the mRNA regulation of heat shock proteins, which are essential components of ER stress response, Hsp40 memberb1 (Hsp40 b1, Dnajb1) was downregulated in myofibroblasts and upregulated in Kupffer cells and T cells; and Hsp40 member c1 (Hsp40 c1, Dnajc1) showed a similar pattern, which is downregulated in myofibroblasts and upregulated in Kupffer cells. In addition, Hsp70 member 1a (Hsp70 1a, Hspa1a) was upregulated in hepatocytes, endothelial cells, Kupffer cells, MDMs, pDCs, and T cells. Hsp70 member 1b (Hsp70 1b, Hspa1b) was similarly upregulated in these cell types, with the addition of B cells. Mitochondrial Hsp70 (Hspa9) was upregulated in hepatocytes, whereas Hsph1 (Hsp110) was upregulated in Kupffer cells, B cells, and T cells.

Consistent with the single-cell sequencing results, RT-qPCR using whole liver homogenates confirmed that Xbp1, C/EBP homologous protein (Chop), and Hsp70 transcripts were upregulated in response to developmental PCB exposure. Collectively, these results suggest that developmental PCB exposure induces a robust ER stress response in the liver.

3.5. Dysregulation of intercellular communication signaling pathways following developmental PCB exposure

Multiple cell types in the liver were targeted by developmental PCB exposure to varying degrees. To further investigate how these cell-type-specific responses may contribute to altered liver pathophysiology, we performed ligand-receptor-centered intercellular communication analysis. This approach identified 9 signaling pathways with significant interaction elements that were enriched and predicted to be dysregulated from developmental exposure to PCBs (Fig. 6A; Supplemental Figs 7 and 8), suggesting a shift in liver intercellular communication and physiology.

Fig. 6.

Fig. 6

(A) Significantly altered predicted cell-cell signaling pathways from perinatal PCB exposure (permutation test P value < .05). Black and red highlights indicate significant predicted signaling pathways enriched in the vehicle and PCB-exposed group, respectively. Predicted decrease in fibronectin (B) and increase in protease-activated receptors (PARs) (C) signaling in liver cell types from perinatal exposure to PCBs. APP, amyloid precursor protein; CCL, CC motif chemokine ligand; CD, cluster of differentiation; FN1, fibronectin 1.

The following signaling pathways were predicted to be downregulated following developmental PCB exposure: (1) fibronectin 1, which is a critical component mediating cell adhesion, migration, and extracellular matrix remodeling66; (2) laminin signaling, which supports the liver architecture and angiogenesis67,68; (3) protease-activated receptors signaling, which is involved in inflammatory crosstalk and vascular remodeling69; (4) collagen signaling, which is essential for matrix support, cell migration, and fibrosis70,71; (5) secreted phosphoprotein 1 (SPP1, osteopontin) signaling, which interacts with integrins and functions as a chemotactic for macrophages72; (6) chemokine signaling pathways (CC motif chemokine ligand) signaling, which modulates the recruitment of immune cells, such as monocytes, T cells, and NK cells73; as well as (7) galectin signaling, which regulates cell death and immune modulation.74

Amyloid precursor protein signaling in the liver mediates inflammatory response, oxidative stress, and cytokine release.75,76 In addition to the predicted downregulated signaling pathways, amyloid precursor protein signaling was predicted to be upregulated by developmental PCB exposure. CD45 (protein tyrosine phosphatase receptor, Ptprc) signaling is a marker of infiltrating lymphocytes, Kupffer cells, and monocytes and macrophages.77,78 CD45 signaling was predicted to be upregulated by developmental PCB exposure. In summary, developmental exposure to PCBs dysregulated predicted signaling pathways that involve impaired immune activation and tissue remodeling.

4. Discussion

In the present study, we used single cell transcriptomics to investigate liver cell-type-specific responses to developmental exposure to the Fox River PCB mixture in developing mouse liver (Fig. 7). Our findings revealed that developmental PCB exposure leads to transcriptional alterations in key pathways related to metabolic function, immune regulation, and intercellular communication. Kupffer cells, hepatocytes, endothelial cells, and myofibroblasts exhibited the most prominent transcriptional changes, indicating they are the primary targets of PCB-induced hepatotoxicity.

Fig. 7.

Fig. 7

Summary of key findings.

Notably, developmental PCB exposure dysregulated the expression of many genes involved in xenobiotic biotransformation, insulin signaling and regulation, and ER stress response in a cell-type-specific manner. Our ligand-receptor interaction analysis further identified widespread alterations in intercellular communications. Our findings also suggested that dysregulated tissue homeostasis and immune signaling may be key mechanisms driving PCB-mediated hepatotoxicity.

Hepatocytes were the main cell type targeted by developmental PCB exposure, exhibiting broad dysregulation of genes involved in xenobiotic metabolism and transport. In hepatocytes, developmental PCB exposure upregulated Cyp1a2, Cyp2b10, Cyp3a11, and Cyp4a10, which are the prototypical target genes for AHR,79 CAR,80 PXR,81 and PPARα, respectively82 (Fig. 3), suggesting the activation of these transcription factors. In addition, many phase I metabolism enzymes, including those in the Ces, Akr, Gst, and Sult families, were also upregulated in hepatocytes by developmental PCB exposure. Hepatocytes exhibited increased expression of many basolateral uptake transporters, including Oct1, Ntcp, and Oatp1b2, and decreased expression of many efflux transporters (Mrp2, Bsep, Mdr2, and Mate1). The upregulation of key xenobiotic and lipid-sensing transcription factors and drug-processing genes as well as the coordinate regulation uptake and efflux transporters may serve as a compensatory mechanism to fight against PCB insult and contribute to altered kinetics of other xenobiotics from the environment.

One prominent observation was the PCB-mediated downregulation of insulin signaling and glucose metabolism-related pathways in hepatocytes (Figs 2 and 4). These findings align with previous studies showing that mainly dioxin-like PCBs disrupt insulin signaling and glucose metabolism, whereas less is known about complex PCB mixtures primarily composed of non-dioxin-like PCBs. Exposure to Aroclor 1254 impaired key components of insulin signaling in mice.83 Coexposure to interesterified palm oil and PCB 126 exacerbated inflammation, morphological liver changes, and dysregulated carbohydrate metabolism in mice.84 PCB 126 dysregulated lipid metabolism and decreased polyunsaturated fatty acids in HepaRG cells.85 PCB 126 and Aroclor 1254 exposure, in separate studies, decreased hepatic glucose production and downregulated genes involved in gluconeogenesis and glucose transport in rats and mice.86,87 Furthermore, previous work reported that specific components of insulin signaling and glucose metabolism were downregulated by exposure to PCBs. For example, PCB 126 decreased hepatic G6pc gene expression in rats,88 PCB 169 decreased hepatic expression of Cpt1a in mice,89 and circulating LEPR expression in children negatively correlated with PCB exposure levels in blood.90 In line with previous findings, our results further support the disruption of insulin signaling and glucose metabolism by exposure to PCBs.

We and others have indicated that ER stress is likely a key mechanism underlying PCB-induced hepatotoxicity. We previously showed that exposure to the Fox River PCB mixture displayed ER stress-related transcriptomic signatures, which are modulated by the microbiome in mice.29 Similarly, a single exposure to PCB 126 in rats upregulated hepatic GRP78 at both the mRNA and protein levels, an effect associated with metabolic disruption.91 In HepG2 cells, PCB quinone, an oxidative PCB metabolite, upregulated ER stress markers, including GRP78, GRP94, and CHOP, and induced ER structural abnormalities.92 Additionally, activation of the IRE1a-XBP1 pathway was observed following exposure to a PCB mixture (Aroclor 1254), which was associated with hepatic lipid accumulation in adolescent mice.93

Although key ER stress-related genes were upregulated in the whole liver following maternal PCB exposure (Figs 5B and C), hepatocytes displayed signatures associated with unresolved or escalating ER stress. In contrast, myofibroblasts and endothelial cells have either resolved or suppressed UPR pathways as a potential compensatory mechanism to avoid apoptosis or to maintain vascular homeostasis. Cell-type-specific regulation of ER stress components following PCB exposure via the maternal diet suggests a temporal response to ER stress or a divergence in key stress response mechanisms that depend on each cell type, including the UPR, protein folding chaperones, and regulators Xbp1, a key transcription factor that is activated during ER stress,94 and Serp1, which supports protein folding and protects cells from ER stress-induced apoptosis.95 DnaJ heat shock protein members B1 and C1 (Dnajb1 and Dnajc1, respectively) are members of the heat shock protein 40 (Hsp40), which facilitates ER-associated degradation and recruits the immunoglobulin binding protein during ER stress.96,97 Hsp family A members 1a and 1b (Hspa1a and Hspa1b, respectively) encode Hsp70, which binds misfolded proteins during ER stress.98 Hsp family A member 9 (Hspa9) is a mitochondrial Hsp70 that coordinates the mitochondrial response to ER stress.99 Hsp family H member 1 (Hsph1, also known as Hsp110) enhances the refolding capacity of Hsp70 and stabilizes denatured proteins.100 ER stress is linked to downregulated insulin signaling, altered energy, and fatty acid metabolism,101, 102, 103, 104 which may overall exacerbate hepatotoxicity and metabolic dysfunction from PCB exposure.

We showed that nonparenchymal cells, particularly Kupffer cells and endothelial cells, are also primarily impacted by developmental PCB exposure. PCB exposure increased the proportions of Kupffer cells and endothelial cells, which displayed prominent transcriptomic responses compared with other nonparenchymal cells (Fig. 2). Specifically, Kupffer cells and endothelial cells exhibited upregulated signatures of cell migration and downregulated signatures associated with hepatic immune response (Fig. 2), indicating tissue damage and matrix remodeling. These results were further supported by alterations in intercellular communication involved in vascular remodeling, cell migration, and immune modulation targeting nonparenchymal cells (Fig. 6; Supplemental Fig. 8).

Our results align with previous studies on PCB exposure and the toxicity to endothelial cells and Kupffer cells. Dioxin-like PCBs increase oxidative stress in endothelial cells and activate proinflammatory pathways that lead to cell dysfunction.105 PCB exposure in mice fed a methionine-choline-deficient diet resulted in extrahepatic toxicity, including upregulated circulating inflammatory biomarkers, suggesting endothelial cell dysfunction.26 PCB 126-induced endothelial cell inflammation that leads to increased expression of adhesion molecules106 as well as circulating levels of vascular inflammation markers that suggest endothelial cell dysfunction in mice.27 PCB 126 polarized macrophages in vitro toward a proinflammatory phenotype and upregulated chemokines that facilitate cell recruitment and infiltration.107 In rat Kupffer cells, chronic exposure to PCBs results in iron accumulation,108 which is linked to increased oxidative stress and impaired function.109 In summary, our findings, together with previous studies, indicate that maternal exposure to PCBs leads to injury in nonparenchymal cells, including endothelial cells and Kupffer cells in the offspring. These results suggest that these nonparenchymal cells may play crucial roles in modulating the response of the liver to PCB exposure.

The present study has several key limitations that warrant follow-up investigations of the impacts of maternal PCB exposure on hepatic cell types in the developing offspring. The results of the present study are based on single cell transcriptomic data. Functional assays, such as western blot, metabolomics, glucose tolerance tests, and mitochondrial respiration assays, are needed to validate pathway-level conclusions regarding ER stress and altered insulin signaling and energy metabolism caused by PCB exposure. Additional endpoints, such as liver histology, liver-to-body weight ratios, markers of liver functions (eg, serum alanine aminotransferase and aspartate aminotransferase), and oxidative stress markers can complement the molecular findings and serve to contextualize the transcriptomic alterations from developmental PCB exposure. The activation of xenobiotic- and lipid-sensing transcription factors, such as AHR, PXR, CAR, and PPARα, can be measured through cellular translocation assays, transcription factor binding, or transcription factor activation assays. Ligand-receptor interactions across cell types can be measured via additional experiments, including spatial transcriptomics or secretome profiling. The present study investigated the cell type-specific responses shortly after developmental PCB exposure in juvenile female mice. PCBs have been shown to disrupt endocrine signaling and display biological sex-specific outcomes.110, 111, 112 Follow-up studies using mice of both sexes will be needed to distinguish sex-specific vulnerability in hepatic cell type-specific responses following maternal PCB exposure. Furthermore, similar to previous studies,45,113,114 future work should assess whether altered hepatic cell-type-specific responses persist into adulthood or lead to phenotypic changes later in life. Despite these limitations, our study demonstrates that developmental PCB exposure leads to cell type-specific transcriptomic alterations in the mouse liver. Our findings highlight the multifaceted impact of developmental environmental toxicant exposure on liver physiology and contribute to the understanding of developmental origins of metabolic and inflammatory liver disease.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgments

Financial support

This work was supported by the National Institute of Environmental Health Sciences and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (ES005605, ES013661, ES014901, ES030197, ES031098, and F31DK139707), as well as the UW T32ES007032 and the EHMBRACE Center.

Data availability

Data associated with this study can be accessed on Dryad (https://doi.org/10.5061/dryad.p2ngf1w3m) and Figshare (https://doi.org/10.6084/m9.figshare.29286497).

CRediT authorship contribution statement

Joe Jongpyo Lim: Conceptualization, Methodology, Software, Investigation, Writing – Original Draft, Writing – Original Draft, Visualization, Project administration. Youjun Suh: Conceptualization, Investigation, Project administration. Resources, Writing – Review & Editing. Xueshu Li. Conceptualization, Investigation, Resources, Writing – Review & Editing. Rebecca Wilson: Conceptualization, Investigation, Resources, Writing – Review & Editing. Hans-Joachim Lehmler: Resources, Project administration, Funding acquisition, Writing – Review & Editing. Pemela Lein: Resources, Project administration, Funding acquisition, Writing – Review & Editing. Julia Yue Cui: Resources, Project administration, Funding acquisition, Writing – Review & Editing.

Footnotes

This article has supplemental material available at dmd.aspetjournals.org

Supplemental material

Supplementary Material 1
mmc1.pdf (2MB, pdf)
Supplementary Material 2
mmc2.xlsx (637.4KB, xlsx)

References

  • 1.Erickson M.D., Kaley R.G., 2nd Applications of polychlorinated biphenyls. Environ Sci Pollut Res Int. 2011;18(2):135–151. doi: 10.1007/s11356-010-0392-1. [DOI] [PubMed] [Google Scholar]
  • 2.Ross G. The public health implications of polychlorinated biphenyls (PCBs) in the environment. Ecotoxicol Environ Saf. 2004;59(3):275–291. doi: 10.1016/j.ecoenv.2004.06.003. [DOI] [PubMed] [Google Scholar]
  • 3.Klocke C., Lein P.J. Evidence implicating non-dioxin-like congeners as the key mediators of polychlorinated biphenyl (PCB) developmental neurotoxicity. Int J Mol Sci. 2020;21(3):1013. doi: 10.3390/ijms21031013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Melymuk L., Blumenthal J., Sáňka O., et al. Persistent problem: global challenges to managing PCBs. Environ Sci Technol. 2022;56(12):9029–9040. doi: 10.1021/acs.est.2c01204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhu M., Yuan Y., Yin H., et al. Environmental contamination and human exposure of polychlorinated biphenyls (PCBs) in China: a review. Sci Total Environ. 2022;805 doi: 10.1016/j.scitotenv.2021.150270. [DOI] [PubMed] [Google Scholar]
  • 6.Jacobson J.L., Fein G.G., Jacobson S.W., Schwartz P.M., Dowler J.K. The transfer of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs) across the human placenta and into maternal milk. Am J Public Health. 1984;74(4):378–379. doi: 10.2105/ajph.74.4.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang S.L., Lin C.Y., Leon Guo Y., Lin L.Y., Chou W.L., Chang L.W. Infant exposure to polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls (PCDD/Fs, PCBs)––correlation between prenatal and postnatal exposure. Chemosphere. 2004;54(10):1459–1473. doi: 10.1016/j.chemosphere.2003.08.012. [DOI] [PubMed] [Google Scholar]
  • 8.Winneke G., Walkowiak J., Lilienthal H. PCB-induced neurodevelopmental toxicity in human infants and its potential mediation by endocrine dysfunction. Toxicology. 2002;181-182:161–165. doi: 10.1016/s0300-483x(02)00274-3. [DOI] [PubMed] [Google Scholar]
  • 9.Montano L., Pironti C., Pinto G., et al. Polychlorinated biphenyls (PCBs) in the environment: Occupational and exposure events, effects on human health and fertility. Toxics. 2022;10(7):365. doi: 10.3390/toxics10070365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Casas M., Nieuwenhuijsen M., Martínez D., et al. Prenatal exposure to PCB-153, p,p′-DDE and birth outcomes in 9000 mother–child pairs: exposure–response relationship and effect modifiers. Environ Int. 2015;74:23–31. doi: 10.1016/j.envint.2014.09.013. [DOI] [PubMed] [Google Scholar]
  • 11.Fiolet T., Mahamat-Saleh Y., Frenoy P., Kvaskoff M., Romana Mancini F. Background exposure to polychlorinated biphenyls and all-cause, cancer-specific, and cardiovascular-specific mortality: a systematic review and meta-analysis. Environ Int. 2021;154 doi: 10.1016/j.envint.2021.106663. [DOI] [PubMed] [Google Scholar]
  • 12.Badley J.R., Wilson R.J., Werner A.S., Smiley-Jewell S.M., Lein P.J. In: Kodavanti P.R.S., Aschner M., Costa L.G., editors. Vol. 10. Elsevier; 2023. The neurotoxicity of polychlorinated biphenyls (PCBs) pp. 27–79. (Advances in Neurotoxicology). [Google Scholar]
  • 13.Keil-Stietz K., Lein P.J. Gene×environment interactions in autism spectrum disorders. Curr Top Dev Biol. 2023;152:221–284. doi: 10.1016/bs.ctdb.2022.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Balalian A.A., Stingone J.A., Kahn L.G., et al. Perinatal exposure to polychlorinated biphenyls (PCBs) and child neurodevelopment: a comprehensive systematic review of outcomes and methodological approaches. Environ Res. 2024;252 doi: 10.1016/j.envres.2024.118912. [DOI] [PubMed] [Google Scholar]
  • 15.Sethi S., Keil Stietz K.P., Valenzuela A.E., et al. Developmental exposure to a human-relevant polychlorinated biphenyl mixture causes behavioral phenotypes that vary by sex and genotype in juvenile mice expressing human mutations that modulate neuronal calcium. Front Neurosci. 2021;15 doi: 10.3389/fnins.2021.766826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rude K.M., Pusceddu M.M., Keogh C.E., et al. Developmental exposure to polychlorinated biphenyls (PCBs) in the maternal diet causes host-microbe defects in weanling offspring mice. Environ Pollut. 2019;253:708–721. doi: 10.1016/j.envpol.2019.07.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dickerson S.M., Cunningham S.L., Patisaul H.B., Woller M.J., Gore A.C. Endocrine disruption of brain sexual differentiation by developmental PCB exposure. Endocrinology. 2011;152(2):581–594. doi: 10.1210/en.2010-1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kostyniak P.J., Hansen L.G., Widholm J.J., et al. Formulation and characterization of an experimental PCB mixture designed to mimic human exposure from contaminated fish. Toxicol Sci. 2005;88(2):400–411. doi: 10.1093/toxsci/kfi338. [DOI] [PubMed] [Google Scholar]
  • 19.Wilson R.J., Suh Y.P., Dursun I., et al. Developmental exposure to the Fox River PCB mixture modulates behavior in juvenile mice. Neurotoxicology. 2024;103:146–161. doi: 10.1016/j.neuro.2024.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Li X., Suh Y.P., Wilson R.J., Lein P.J., Cui J.Y., Lehmler H.J. Significant metabolic alterations in mouse dams exposed to an environmental mixture of polychlorinated biphenyls (PCBs) during gestation and lactation: Insights into PCB and metabolite profiles. Environ Toxicol Pharmacol. 2024;111(104567) doi: 10.1016/j.etap.2024.104567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.McLauchlan C.A. Allowing relatives to witness resuscitation. BMJ. 1997;314(7086):1044. doi: 10.1136/bmj.314.7086.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Clair H.B., Pinkston C.M., Rai S.N., et al. Liver disease in a residential cohort with elevated polychlorinated biphenyl exposures. Toxicol Sci. 2018;164(1):39–49. doi: 10.1093/toxsci/kfy076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cave M.C., Pinkston C.M., Rai S.N., et al. Circulating MicroRNAs, polychlorinated biphenyls, and environmental liver disease in the Anniston community health survey. Environ Health Perspect. 2022;130(1) doi: 10.1289/ehp9467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Vieira Silva A., Chu I., Feeley M., Bergman Å., Håkansson H., Öberg M. Dose-dependent toxicological effects in rats following a 90-day dietary exposure to PCB-156 include retinoid disruption. Reprod Toxicol. 2022;107:123–139. doi: 10.1016/j.reprotox.2021.09.012. [DOI] [PubMed] [Google Scholar]
  • 25.Deng P., Barney J., Petriello M.C., Morris A.J., Wahlang B., Hennig B. Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunction. Chemosphere. 2019;217:140–149. doi: 10.1016/j.chemosphere.2018.10.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wahlang B., Perkins J.T., Petriello M.C., Hoffman J.B., Stromberg A.J., Hennig B. A compromised liver alters polychlorinated biphenyl-mediated toxicity. Toxicology. 2017;380:11–22. doi: 10.1016/j.tox.2017.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wahlang B., Barney J., Thompson B., et al. Editor’s highlight: PCB126 exposure increases risk for peripheral vascular diseases in a liver injury mouse model. Toxicol Sci. 2017;160(2):256–267. doi: 10.1093/toxsci/kfx180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cheng S.L., Li X., Lehmler H.J., Phillips B., Shen D., Cui J.Y. Gut microbiota modulates interactions between polychlorinated biphenyls and bile acid homeostasis. Toxicol Sci. 2018;166(2):269–287. doi: 10.1093/toxsci/kfy208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lim J.J., Li X., Lehmler H.J., Wang D., Gu H., Cui J.Y. Gut microbiome critically impacts PCB-induced changes in metabolic fingerprints and the hepatic transcriptome in mice. Toxicol Sci. 2020;177(1):168–187. doi: 10.1093/toxsci/kfaa090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gumucio J.J., Miller D.L. Functional implications of liver cell heterogeneity. Gastroenterology. 1981;80(2):393–403. [PubMed] [Google Scholar]
  • 31.Andrews T.S., Atif J., Liu J.C., et al. Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity. Hepatol Commun. 2022;6(4):821–840. doi: 10.1002/hep4.1854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ishibashi H., Nakamura M., Komori A., Migita K., Shimoda S. Liver architecture, cell function, and disease. Semin Immunopathol. 2009;31(3):399–409. doi: 10.1007/s00281-009-0155-6. [DOI] [PubMed] [Google Scholar]
  • 33.Zhang W., Cui Y., Du Y., et al. Liver cell therapies: cellular sources and grafting strategies. Front Med. 2023;17(3):432–457. doi: 10.1007/s11684-023-1002-1. [DOI] [PubMed] [Google Scholar]
  • 34.MacParland S.A., Liu J.C., Ma X.Z., et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018;9(1):4383. doi: 10.1038/s41467-018-06318-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Nemeth E., Baird A.W., O’Farrelly C. Microanatomy of the liver immune system. Semin Immunopathol. 2009;31(3):333–343. doi: 10.1007/s00281-009-0173-4. [DOI] [PubMed] [Google Scholar]
  • 36.Li X., Hefti M.M., Marek R.F., Hornbuckle K.C., Wang K., Lehmler H.J. Assessment of polychlorinated biphenyls and their hydroxylated metabolites in postmortem human brain samples: age and brain region differences. Environ Sci Technol. 2022;56(13):9515–9526. doi: 10.1021/acs.est.2c00581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Li X., Suh Y.P., Cui J.Y., Lehmler H.J. Published online 2023. Dataset for characterization of the Fox River Mixture (FRM) [DOI] [Google Scholar]
  • 38.Li X., Lim J.J., Wang K., et al. The disposition of polychlorinated biphenyls (PCBs) differs between germ-free and conventional mice. Environ Toxicol Pharmacol. 2022;92 doi: 10.1016/j.etap.2022.103854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Korsunsky I., Millard N., Fan J., et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289–1296. doi: 10.1038/s41592-019-0619-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Jin S., Guerrero-Juarez C.F., Zhang L., et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. doi: 10.1038/s41467-021-21246-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Adrian Alexa J.R. 2017. topGO. Bioconductor. [DOI] [Google Scholar]
  • 42.Gu Z., Eils R., Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847–2849. doi: 10.1093/bioinformatics/btw313. [DOI] [PubMed] [Google Scholar]
  • 43.Gu Z. Complex heatmap visualization. Imeta. 2022;1(3) doi: 10.1002/imt2.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lim J.J., Klaassen C.D., Cui J.Y. Deciphering the cell type-specific and zonal distribution of drug-metabolizing enzymes, transporters, and transcription factors in livers of mice using single-cell transcriptomics. Drug Metab Dispos. 2025;53(2) doi: 10.1016/j.dmd.2024.100029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lim J.J., Goedken M., Jin Y., Gu H., Cui J.Y. Single-cell transcriptomics unveiled that early life BDE-99 exposure reprogrammed the gut-liver axis to promote a proinflammatory metabolic signature in male mice at late adulthood. Toxicol Sci. 2024;200(1):114–136. doi: 10.1093/toxsci/kfae047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Guilliams M., Bonnardel J., Haest B., et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell. 2022;185(2):379–396.e38. doi: 10.1016/j.cell.2021.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Siwicki M., Gort-Freitas N.A., Messemaker M., et al. Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy. Sci Immunol. 2021;6(61) doi: 10.1126/sciimmunol.abi7083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Laskin D.L. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis. 1990;10(4):293–304. doi: 10.1055/s-2008-1040485. [DOI] [PubMed] [Google Scholar]
  • 49.Almazroo O.A., Miah M.K., Venkataramanan R. Drug metabolism in the liver. Clin Liver Dis. 2017;21(1):1–20. doi: 10.1016/j.cld.2016.08.001. [DOI] [PubMed] [Google Scholar]
  • 50.Bemis J.C., Nazarenko D.A., Gasiewicz T.A. Coplanar polychlorinated biphenyls activate the aryl hydrocarbon receptor in developing tissues of two TCDD-responsive lacZ mouse lines. Toxicol Sci. 2005;87(2):529–536. doi: 10.1093/toxsci/kfi260. [DOI] [PubMed] [Google Scholar]
  • 51.Al-Salman F., Plant N. Non-coplanar polychlorinated biphenyls (PCBs) are direct agonists for the human pregnane-X receptor and constitutive androstane receptor, and activate target gene expression in a tissue-specific manner. Toxicol Appl Pharmacol. 2012;263(1):7–13. doi: 10.1016/j.taap.2012.05.016. [DOI] [PubMed] [Google Scholar]
  • 52.Wahlang B., Falkner K.C., Clair H.B., et al. Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. Toxicol Sci. 2014;140(2):283–297. doi: 10.1093/toxsci/kfu083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Routti H., Berg M.K., Lille-Langøy R., et al. Environmental contaminants modulate the transcriptional activity of polar bear (Ursus maritimus) and human peroxisome proliferator-activated receptor alpha (PPARA) Sci Rep. 2019;9(1):6918. doi: 10.1038/s41598-019-43337-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Rakhshandehroo M., Knoch B., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010;2010:1–20. doi: 10.1155/2010/612089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Carobbio S., Hagen R.M., Lelliott C.J., et al. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes. 2013;62(11):3697–3708. doi: 10.2337/db12-1748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Xu Y., Tao J., Yu X., et al. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression. JCI Insight. 2021;6(19) doi: 10.1172/jci.insight.147038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Azzu V., Vacca M., Kamzolas I., et al. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. Mol Metab. 2021;48 doi: 10.1016/j.molmet.2021.101210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Engelking L.J., Kuriyama H., Hammer R.E., et al. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest. 2004;113(8):1168–1175. doi: 10.1172/JCI20978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Feng X., Zhang L., Xu S., Shen A.Z. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: an updated review. Prog Lipid Res. 2020;77 doi: 10.1016/j.plipres.2019.101006. [DOI] [PubMed] [Google Scholar]
  • 60.Marcolongo P., Fulceri R., Gamberucci A., Czegle I., Banhegyi G., Benedetti A. Multiple roles of glucose-6-phosphatases in pathophysiology: state of the art and future trends. Biochim Biophys Acta. 2013;1830(3):2608–2618. doi: 10.1016/j.bbagen.2012.12.013. [DOI] [PubMed] [Google Scholar]
  • 61.Geng Y., Ju Y., Ren F., et al. Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2. J Biol Chem. 2014;289(16):11230–11241. doi: 10.1074/jbc.M113.544999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Lee J., Pilch P.F. The insulin receptor: structure, function, and signaling. Am J Physiol. 1994;266(2 Pt 1):C319–C334. doi: 10.1152/ajpcell.1994.266.2.C319. [DOI] [PubMed] [Google Scholar]
  • 63.Schlaepfer I.R., Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology. 2020;161(2) doi: 10.1210/endocr/bqz046. [DOI] [PubMed] [Google Scholar]
  • 64.Yabe D., Komuro R., Liang G., Goldstein J.L., Brown M.S. Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc Natl Acad Sci U S A. 2003;100(6):3155–3160. doi: 10.1073/pnas.0130116100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Polyzos S.A., Kountouras J., Mantzoros C.S. Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism. 2015;64(1):60–78. doi: 10.1016/j.metabol.2014.10.012. [DOI] [PubMed] [Google Scholar]
  • 66.Zollinger A.J., Smith M.L. Fibronectin, the extracellular glue. Matrix Biol. 2017;60-61:27–37. doi: 10.1016/j.matbio.2016.07.011. [DOI] [PubMed] [Google Scholar]
  • 67.Simon-Assmann P., Orend G., Mammadova-Bach E., Spenlé C., Lefebvre O. Role of laminins in physiological and pathological angiogenesis. Int J Dev Biol. 2011;55(4-5):455–465. doi: 10.1387/ijdb.103223ps. [DOI] [PubMed] [Google Scholar]
  • 68.Goddi A., Schroedl L., Brey E.M., Cohen R.N. Laminins in metabolic tissues. Metabolism. 2021;120 doi: 10.1016/j.metabol.2021.154775. [DOI] [PubMed] [Google Scholar]
  • 69.Peach C.J., Edgington-Mitchell L.E., Bunnett N.W., Schmidt B.L. Protease-activated receptors in health and disease. Physiol Rev. 2023;103(1):717–785. doi: 10.1152/physrev.00044.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Arteel G.E., Naba A. The liver matrisome—looking beyond collagens. JHEP Rep. 2020;2(4) doi: 10.1016/j.jhepr.2020.100115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Zhang D., Zhang Y., Sun B. The molecular mechanisms of liver fibrosis and its potential therapy in application. Int J Mol Sci. 2022;23(20) doi: 10.3390/ijms232012572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Han H., Ge X., Komakula S.S.B., et al. Macrophage-derived osteopontin (SPP1) protects from nonalcoholic steatohepatitis. Gastroenterology. 2023;165(1):201–217. doi: 10.1053/j.gastro.2023.03.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Marra F., Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577–594.e1. doi: 10.1053/j.gastro.2014.06.043. [DOI] [PubMed] [Google Scholar]
  • 74.An Y., Xu S., Liu Y., et al. Role of galectins in the liver diseases: a systematic review and meta-analysis. Front Med (Lausanne) 2021;8 doi: 10.3389/fmed.2021.744518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Garcia J., Chang R., Steinberg R.A., et al. Modulation of hepatic amyloid precursor protein and lipoprotein receptor-related protein 1 by chronic alcohol intake: potential link between liver steatosis and amyloid-β. Front Physiol. 2022;13 doi: 10.3389/fphys.2022.930402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Guo Y., Wang Q., Chen S., Xu C. Functions of amyloid precursor protein in metabolic diseases. Metabolism. 2021;115 doi: 10.1016/j.metabol.2020.154454. [DOI] [PubMed] [Google Scholar]
  • 77.Hermiston M.L., Xu Z., Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 2003;21(1):107–137. doi: 10.1146/annurev.immunol.21.120601.140946. [DOI] [PubMed] [Google Scholar]
  • 78.De Simone G., Andreata F., Bleriot C., et al. Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming. Immunity. 2021;54(9):2089–2100.e8. doi: 10.1016/j.immuni.2021.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Vogel C.F.A., Van Winkle L.S., Esser C., Haarmann-Stemmann T. The aryl hydrocarbon receptor as a target of environmental stressors—implications for pollution mediated stress and inflammatory responses. Redox Biol. 2020;34 doi: 10.1016/j.redox.2020.101530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Ding X., Lichti K., Kim I., Gonzalez F.J., Staudinger J.L. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J Biol Chem. 2006;281(36):26540–26551. doi: 10.1074/jbc.M600931200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Cui J.Y., Gunewardena S.S., Rockwell C.E., Klaassen C.D. ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res. 2010;38(22):7943–7963. doi: 10.1093/nar/gkq654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Patsouris D., Reddy J.K., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology. 2006;147(3):1508–1516. doi: 10.1210/en.2005-1132. [DOI] [PubMed] [Google Scholar]
  • 83.Zhang S., Wu T., Chen M., et al. Chronic exposure to Aroclor 1254 disrupts glucose homeostasis in male mice via inhibition of the insulin receptor signal pathway. Environ Sci Technol. 2015;49(16):10084–10092. doi: 10.1021/acs.est.5b01597. [DOI] [PubMed] [Google Scholar]
  • 84.Teixeira A.V.S., Quitete F.T., Martins B.C., et al. Metabolic consequences of interesterified palm oil and PCB-126 co-exposure in C57BL/6 mice. Food Chem Toxicol. 2024;192 doi: 10.1016/j.fct.2024.114965. [DOI] [PubMed] [Google Scholar]
  • 85.Mesnage R., Biserni M., Balu S., et al. Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in HepaRG liver cells exposed to PCB 126. Arch Toxicol. 2018;92(8):2533–2547. doi: 10.1007/s00204-018-2235-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Gadupudi G.S., Klaren W.D., Olivier A.K., Klingelhutz A.J., Robertson L.W. PCB126-induced disruption in gluconeogenesis and fatty acid oxidation precedes fatty liver in male rats. Toxicol Sci. 2016;149(1):98–110. doi: 10.1093/toxsci/kfv215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Gray S.L., Shaw A.C., Gagne A.X., Chan H.M. Chronic exposure to PCBs (Aroclor 1254) exacerbates obesity-induced insulin resistance and hyperinsulinemia in mice. J Toxicol Environ Health A. 2013;76(12):701–715. doi: 10.1080/15287394.2013.796503. [DOI] [PubMed] [Google Scholar]
  • 88.Gadupudi G.S., Elser B.A., Sandgruber F.A., Li X., Gibson-Corley K.N., Robertson L.W. PCB126 inhibits the activation of AMPK-CREB signal transduction required for energy sensing in liver. Toxicol Sci. 2018;163(2):440–453. doi: 10.1093/toxsci/kfy041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Wei Y., Zhou G., Lv G., et al. PCB169 exposure aggravated the development of non-alcoholic fatty liver in high-fat diet-induced male C57BL/6 mice. Front Nutr. 2024;11 doi: 10.3389/fnut.2024.1350146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Mondal T., Loffredo C.A., Trnovec T., et al. Gene expression signatures in PCB-exposed Slovak children in relation to their environmental exposures and socio-physical characteristics. Environ Sci Pollut Res Int. 2022;29(40):60531–60541. doi: 10.1007/s11356-022-20018-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Chapados N.A., Boucher M.P. Liver metabolic disruption induced after a single exposure to PCB126 in rats. Environ Sci Pollut Res Int. 2017;24(2):1854–1861. doi: 10.1007/s11356-016-7939-8. [DOI] [PubMed] [Google Scholar]
  • 92.Xu D., Su C., Song X., et al. Polychlorinated biphenyl quinone induces endoplasmic reticulum stress, unfolded protein response, and calcium release. Chem Res Toxicol. 2015;28(6):1326–1337. doi: 10.1021/acs.chemrestox.5b00124. [DOI] [PubMed] [Google Scholar]
  • 93.Ruan J., Guo J., Huang Y., Mao Y., Yang Z., Zuo Z. Adolescent exposure to environmental level of PCBs (Aroclor 1254) induces non-alcoholic fatty liver disease in male mice. Environ Res. 2020;181 doi: 10.1016/j.envres.2019.108909. [DOI] [PubMed] [Google Scholar]
  • 94.Park S.M., Kang T.I., So J.S. Roles of XBP1s in transcriptional regulation of target genes. Biomedicines. 2021;9(7):791. doi: 10.3390/biomedicines9070791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Hu L., Saulinskas E.F., Johnson P., Harrington P.B. Development of an expert system for amino acid sequence identification. Comput Appl Biosci. 1996;12(4):311–318. doi: 10.1093/bioinformatics/12.4.311. [DOI] [PubMed] [Google Scholar]
  • 96.Chen K.C., Qu S., Chowdhury S., et al. The endoplasmic reticulum HSP40 co-chaperone ERdj3/DNAJB11 assembles and functions as a tetramer. EMBO J. 2017;36(15):2296–2309. doi: 10.15252/embj.201695616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Pobre K.F.R., Poet G.J., Hendershot L.M. The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: getting by with a little help from ERdj friends. J Biol Chem. 2019;294(6):2098–2108. doi: 10.1074/jbc.REV118.002804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Chen W., Wang Z., Ji J., et al. The regulatory mechanism of HSP70 in endoplasmic reticulum stress in pepsin-treated laryngeal epithelium cells and laryngeal cancer cells. Aging (Albany NY) 2022;14(20):8486–8497. doi: 10.18632/aging.204356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Gorrell L., Makareeva E., Omari S., Otsuru S., Leikin S. ER, mitochondria, and ISR regulation by mt-HSP70 and ATF5 upon procollagen misfolding in osteoblasts. Adv Sci (Weinh) 2022;9(29) doi: 10.1002/advs.202201273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Easton D.P., Kaneko Y., Subjeck J.R. The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s. Cell Stress Chaperones. 2000;5(4):276–290. doi: 10.1379/1466-1268(2000)005<0276:thagsp>2.0.co;2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Lei L., Gao W., Loor J.J., et al. Reducing hepatic endoplasmic reticulum stress ameliorates the impairment in insulin signaling induced by high levels of β-hydroxybutyrate in bovine hepatocytes. J Dairy Sci. 2021;104(12):12845–12858. doi: 10.3168/jds.2021-20611. [DOI] [PubMed] [Google Scholar]
  • 102.Park T.J., Park S.Y., Lee H.J., Abd El-Aty A.M., Jeong J.H., Jung T.W. α-ketoisocaproic acid promotes ER stress through impairment of autophagy, thereby provoking lipid accumulation and insulin resistance in murine preadipocytes. Biochem Biophys Res Commun. 2022;603:109–115. doi: 10.1016/j.bbrc.2022.03.010. [DOI] [PubMed] [Google Scholar]
  • 103.Lemmer I.L., Willemsen N., Hilal N., Bartelt A. A guide to understanding endoplasmic reticulum stress in metabolic disorders. Mol Metab. 2021;47 doi: 10.1016/j.molmet.2021.101169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Ma K., Zhang Y., Zhao J., Zhou L., Li M. Endoplasmic reticulum stress: bridging inflammation and obesity-associated adipose tissue. Front Immunol. 2024;15 doi: 10.3389/fimmu.2024.1381227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Hennig B., Hammock B.D., Slim R., Toborek M., Saraswathi V., Robertson L.W. PCB-induced oxidative stress in endothelial cells: modulation by nutrients. Int J Hyg Environ Health. 2002;205(1-2):95–102. doi: 10.1078/1438-4639-00134. [DOI] [PubMed] [Google Scholar]
  • 106.Han S.G., Han S.S., Toborek M., Hennig B. EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes. Toxicol Appl Pharmacol. 2012;261(2):181–188. doi: 10.1016/j.taap.2012.03.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Wang C., Petriello M.C., Zhu B., Hennig B. PCB 126 induces monocyte/macrophage polarization and inflammation through AhR and NF-κB pathways. Toxicol Appl Pharmacol. 2019;367:71–81. doi: 10.1016/j.taap.2019.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Whysner J., Wang C.X. Hepatocellular iron accumulation and increased cell proliferation in polychlorinated biphenyl-exposed Sprague-Dawley rats and the development of hepatocarcinogenesis. Toxicol Sci. 2001;62(1):36–45. doi: 10.1093/toxsci/62.1.36. [DOI] [PubMed] [Google Scholar]
  • 109.Cui Y., Gutierrez S., Ariai S., et al. Non-heme iron overload impairs monocyte to macrophage differentiation via mitochondrial oxidative stress. Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.998059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Brennan E., Cunningham T.K., Sathyapalan T., Atkin S.L. The association of the polychlorinated biphenyl class of endocrine disruptors with polycystic ovary syndrome and thyroid dysfunction. J Endocr Soc. 2021;5(Supplement_1) [Google Scholar]
  • 111.Liberman D.A., Walker K.A., Gore A.C., Bell M.R. Sex-specific effects of developmental exposure to polychlorinated biphenyls on neuroimmune and dopaminergic endpoints in adolescent rats. Neurotoxicol Teratol. 2020;79 doi: 10.1016/j.ntt.2020.106880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Wahlang B., Jin J., Hardesty J.E., et al. Identifying sex differences arising from polychlorinated biphenyl exposures in toxicant-associated liver disease. Food Chem Toxicol. 2019;129:64–76. doi: 10.1016/j.fct.2019.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Lim J.J., Dutta M., Dempsey J.L., et al. Neonatal exposure to BPA, BDE-99, and PCB produces persistent changes in hepatic transcriptome associated with gut dysbiosis in adult mouse livers. Toxicol Sci. 2021;184(1):83–103. doi: 10.1093/toxsci/kfab104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Kim S., Li H., Jin Y., et al. Maternal PBDE exposure disrupts gut microbiome and promotes hepatic pro-inflammatory signaling in humanized PXR-transgenic mouse offspring over time. Toxicol Sci. Published online June 2, 2023 doi: 10.1093/toxsci/kfad056. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1
mmc1.pdf (2MB, pdf)
Supplementary Material 2
mmc2.xlsx (637.4KB, xlsx)

Data Availability Statement

Data associated with this study can be accessed on Dryad (https://doi.org/10.5061/dryad.p2ngf1w3m) and Figshare (https://doi.org/10.6084/m9.figshare.29286497).


Articles from Drug Metabolism and Disposition are provided here courtesy of American Society for Pharmacology and Experimental Therapeutics

RESOURCES